In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y. Shadrin IY, Newby LK. Ann Intern Med 2024;177:JC26.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shadrin IY, Newby LK. In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y. Ann Intern Med 2024;177:JC26.
PMID: 38437696